{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:26:12Z","timestamp":1792103172115,"version":"4.4.0"},"reference-count":116,"publisher":"American Society for Clinical Investigation","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,1,19]]},"DOI":"10.1172\/jci142243","type":"journal-article","created":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T14:01:33Z","timestamp":1610978493000},"source":"Crossref","is-referenced-by-count":232,"title":["Pharmacological treatment of hyperglycemia in type 2 diabetes"],"prefix":"10.1172","volume":"131","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7500-7854","authenticated-orcid":false,"given":"Simeon I.","family":"Taylor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhinous Shahidzadeh","family":"Yazdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0958-7197","authenticated-orcid":false,"given":"Amber L.","family":"Beitelshees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"232","published-online":{"date-parts":[[2021,1,19]]},"reference":[{"key":"B1","unstructured":"Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2020. https:\/\/www.cdc.gov\/diabetes\/library\/features\/diabetes-stat-report.html Updated February 11, 2020. Accessed November 18, 2020"},{"issue":"suppl 1","key":"B2","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.2337\/dc20-S002","article-title":"2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2020","volume":"43","author":"American Diabetes Association","year":"2020","journal-title":"Diabetes Care"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.2337\/db09-9028"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199309303291401"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa052187"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)07019-6"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)07037-8"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0806470"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0802743"},{"key":"B10","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b4909","article-title":"The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study","volume":"340","author":"Bonds","year":"2010","journal-title":"BMJ"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-1471"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1001288"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0802987"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0808431"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.20.4.614"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa066224"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.2337\/dc07-2270"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2013.05.004"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2013.05.005"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-013927"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.2337\/dc19-2273"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.2337\/dc13-0356"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2010.02941.x"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.2337\/dc19-2535"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2011.02656.x"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(17)30413-8"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1172\/JCI99820"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.2337\/dc15-2237"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13805"},{"key":"B30","doi-asserted-by":"crossref","unstructured":"Mishriky BM, et al. Do GLP-1RAs SGLT-2is reduce cardiovascular events in women with type 2 diabetes? A systematic review meta-analysis [published online May 18, 2020]. Diabetes Metab. https:\/\/doi: 10.1016\/j.diabet.2020.05.002","DOI":"10.1016\/j.diabet.2020.05.002"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1307684"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1305889"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1501352"},{"key":"B34","doi-asserted-by":"crossref","unstructured":"Rosenstock J, et al. Effect of linagliptin vs glimepiride on major adverse cardiovascular outcomes in patients with type 2 diabetes: the CAROLINA randomized clinical trial [published online September 19, 2019]. JAMA. https: doi: 10.1001\/jama.2019.13772","DOI":"10.1001\/jama.2019.13772"},{"key":"B35","doi-asserted-by":"crossref","DOI":"10.1186\/1475-2840-11-6","article-title":"Saxagliptin for the treatment of type 2 diabetes mellitus: assessing cardiovascular data","volume":"11","author":"Cobble","year":"2012","journal-title":"Cardiovasc Diabetol"},{"key":"B36","doi-asserted-by":"crossref","DOI":"10.1186\/1475-2840-12-3","article-title":"Cardiovascular safety of sitagliptin in patients with type 2 diabetes mellitus: a pooled analysis","volume":"12","author":"Engel","year":"2013","journal-title":"Cardiovasc Diabetol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504720"},{"issue":"21","key":"B38","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N Engl J Med"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1812389"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12888"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.2337\/dbi18-0006"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.2337\/dc17-1096"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.005081"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-1860"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-3167"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1603827"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1607141"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31149-3"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31150-X"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32261-X"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1612917"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1509225"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.2337\/dc19-2251"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67528-9"},{"issue":"suppl 1","key":"B55","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.2337\/dc20-S009","article-title":"9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes\u20142020","volume":"43","author":"American Diabetes Association","year":"2020","journal-title":"Diabetes Care"},{"issue":"19","key":"B56","doi-asserted-by":"crossref","first-page":"e779","DOI":"10.1161\/CIR.0000000000000766","article-title":"Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association","volume":"141","author":"Arnold","year":"2020","journal-title":"Circulation"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz486"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.05.037"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32131-2"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12417"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-018-1116-0"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1911303"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2022190"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.2337\/dc14-0785"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-0917"},{"key":"B66","unstructured":"Bristol Meyers Squib. Annual Report Pursuant To Section 13 Or 15(d) Ot The Securities Exchange Act Of 1934. Form 10-K. United States Securities and Exchange Commission. December 31, 2013. https:\/\/s21.q4cdn.com\/104148044\/files\/doc_financials\/annual_reports\/2013\/BristolMyersSquibb_10K_20140214.pdf Accessed January 6, 2021"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.2337\/dci20-0039"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-0413"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.2337\/db13-1367"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3632"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1210\/er.2018-00117"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32260-8"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30726-8"},{"key":"B74","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8768954","article-title":"Molecular mechanisms by which imeglimin improves glucose homeostasis","volume":"2020","author":"Yaribeygi","year":"2020","journal-title":"J Diabetes Res"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.8b02507"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00009.2016"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-0453"},{"issue":"suppl 2","key":"B78","doi-asserted-by":"crossref","first-page":"S175","DOI":"10.2337\/dcS13-2037","article-title":"Activation of GPR40 as a therapeutic target for the treatment of type 2 diabetes","volume":"36","author":"Burant","year":"2013","journal-title":"Diabetes Care"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61879-5"},{"key":"B80","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107477","article-title":"The therapeutic potential of second and third generation CB1R antagonists","volume":"208","author":"Cinar","year":"2020","journal-title":"Pharmacol Ther"},{"issue":"suppl 2","key":"B81","doi-asserted-by":"crossref","first-page":"S229","DOI":"10.2337\/dc08-s258","article-title":"Efficacy and safety of rimonabant for improvement of multiple cardiometabolic risk factors in overweight\/obese patients: pooled 1-year data from the Rimonabant in Obesity (RIO) program","volume":"31","author":"Van Gaal","year":"2008","journal-title":"Diabetes Care"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.2337\/dc13-2480"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2010.06.006"},{"key":"B84","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2019.00148","article-title":"The central role of glucokinase in glucose homeostasis: a perspective 50 years after demonstrating the presence of the enzyme in islets of langerhans","volume":"10","author":"Matschinsky","year":"2019","journal-title":"Front Physiol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-1200"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1811744"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1515920"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1616011"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(18)30125-6"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(18)30104-9"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00803-X"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199508313330902"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2004.00369.x"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.2337\/dc17-0417"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61206-4"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60976-4"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61267-7"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(13)70214-6"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-2709"},{"issue":"5","key":"B101","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.112.002279","article-title":"Effect of bromocriptine-QR (a quick-release formulation of bromocriptine mesylate) on major adverse cardiovascular events in type 2 diabetes subjects","volume":"1","author":"Gaziano","year":"2012","journal-title":"J Am Heart Assoc"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1172\/JCI13505"},{"key":"B103","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1042\/bj3480607","article-title":"Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain","volume":"348 Pt 3","author":"Owen","year":"2000","journal-title":"Biochem J"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1038\/nature11808"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0125-4"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-019-0146-4"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1911-y"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.09.050"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199803263381303"},{"issue":"2","key":"B110","doi-asserted-by":"crossref","first-page":"198","DOI":"10.2337\/dc15-0488","article-title":"The Primary glucose-lowering effect of metformin resides in the gut, not the circulation: results from short-term pharmacokinetic and 12-week dose-ranging studies","volume":"39","author":"Buse","year":"2016","journal-title":"Diabetes Care"},{"issue":"2 suppl","key":"B111","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S1056-8727(02)00274-X","article-title":"Physiology and pathophysiology of K(ATP) channels in the pancreas and cardiovascular system: a review","volume":"17","author":"Seino","year":"2003","journal-title":"J Diabetes Complications"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(95)90193-0"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60408-4"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.2662"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2019.09.010"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a009191"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1177\/1479164118825376"}],"container-title":["Journal of Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jci.org\/articles\/view\/142243\/files\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T13:37:39Z","timestamp":1691069859000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jci.org\/articles\/view\/142243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,19]]},"references-count":116,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,1,19]]},"published-print":{"date-parts":[[2021,1,19]]}},"alternative-id":["10.1172\/JCI142243"],"URL":"https:\/\/doi.org\/10.1172\/jci142243","relation":{},"ISSN":["0021-9738","1558-8238"],"issn-type":[{"value":"0021-9738","type":"print"},{"value":"1558-8238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,19]]},"article-number":"e142243"}}